Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen A Gelmon

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Clinical Breast Cancer|August 14, 2010
The ongoing debate about nodesKaren A Gelmon
Lancet (London, England)|March 29, 2002
The mammography screening debate: time to move onKaren A Gelmon, Ivo Olivotto
Nature Medicine|February 3, 2025
Immunotherapy boosts responses in hormone receptor-positive breast cancersZahi Mitri, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2023
Prognostic Tests in Early-Stage Hormone Receptor-Positive Breast Cancer: An Opportunity to Refine Personalized Cancer CareNathalie LeVasseur, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Accrual strategies for cancer genetics research: blurred boundariesDaniel Rayson, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2023
Reply to Y. Wang et al and Q. Sui et alNathalie LeVasseur, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2021
Acknowledging Disparities in Hereditary Cancer TestingSophie Sun, Karen A Gelmon
Expert Review of Clinical Pharmacology|August 18, 2018
Olaparib tablets for the treatment of germ line BRCA-mutated metastatic breast cancerDan Le, Karen A Gelmon
Translational Cancer Research|February 27, 2024
Can we successfully define and target BRCA-like breast cancers?Nathalie LeVasseur, Karen A Gelmon
The Oncologist|May 6, 2018
Can We Hang Our Hats on One Percent?Nathalie LeVasseur, Karen A Gelmon
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Clinical Breast Cancer|August 14, 2010
The ongoing debate about nodesKaren A Gelmon
Lancet (London, England)|March 29, 2002
The mammography screening debate: time to move onKaren A Gelmon, Ivo Olivotto
Nature Medicine|February 3, 2025
Immunotherapy boosts responses in hormone receptor-positive breast cancersZahi Mitri, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2023
Prognostic Tests in Early-Stage Hormone Receptor-Positive Breast Cancer: An Opportunity to Refine Personalized Cancer CareNathalie LeVasseur, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Accrual strategies for cancer genetics research: blurred boundariesDaniel Rayson, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2023
Reply to Y. Wang et al and Q. Sui et alNathalie LeVasseur, Karen A Gelmon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2021
Acknowledging Disparities in Hereditary Cancer TestingSophie Sun, Karen A Gelmon
Expert Review of Clinical Pharmacology|August 18, 2018
Olaparib tablets for the treatment of germ line BRCA-mutated metastatic breast cancerDan Le, Karen A Gelmon
Translational Cancer Research|February 27, 2024
Can we successfully define and target BRCA-like breast cancers?Nathalie LeVasseur, Karen A Gelmon
The Oncologist|May 6, 2018
Can We Hang Our Hats on One Percent?Nathalie LeVasseur, Karen A Gelmon
Pageof 15